+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Retrophin Inc - logo

Retrophin is a biopharmaceutical company that is based in San Diego, California. The company’s leading pipeline assets are fosmetpantotenate (RE-024), is a life-threatening neurological disorder that typically begins in early childhood, and sparsentan for focal segmental glomerulosclerosis (FSGS), a serious kidney disorder that often leads to end-stage renal disease. Its marketed products include Chenodal, Cholbam and Thiola. Retrophin was founded in 2011.

From
From
From
From
From
From
From
Thiola 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Thiola 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 19 pages
From
Cholbam 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Cholbam 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 19 pages
From
Glomerulonephritis - Pipeline Insights, 2020 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insights, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Glomerulonephritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 322 pages
From
From
From
Loading Indicator
adroll